Vous êtes ici

BioVaxys Technology Corp.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
BIOV
Indice CSE: 
CSE Composite
Devise: 
CAD

BioVaxys Technology Corp. is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on its DPX™ immune-educating technology platform and its HapTenix© tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization for food allergy, and other immunological diseases. Through a differentiated mechanism of action, the DPX™ platform delivers instruction to the immune system to generate a specific, robust, and persistent immune response. The Company's clinical stage pipeline includes maveropepimut-S (MVP-S), based on the DPX™ platform, and is in Phase IIB clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant Ovarian Cancer. MVP-S delivers antigenic peptides from survivin, a well-recognized cancer antigen commonly overexpressed in advanced cancers, and also delivers an innate immune activator and a universal CD4 T cell helper peptide. MVP-S has been well tolerated and has demonstrated defined clinical benefit in multiple cancer indications as well as the activation of a targeted and sustained, survivin-specific anti-tumor immune response. BioVaxys is also developing DPX™+SurMAGE, a dual-targeted immunotherapy combining antigenic peptides for both the survivin and MAGE-A9 cancer proteins to elicit immune responses to these two distinct cancer antigens simultaneously, DPX™-RSV for Respiratory Syncytial Virus, DPX+rPA for peanut allergy prophylaxis, and BVX-0918, a personalized immunotherapeutic vaccine using its proprietary HapTenix© 'neoantigen' tumor cell construct platform for refractive late-stage ovarian cancer. 

BioVaxys Technology Corp. (BIOV)

0.04 Up
0.005 (14.29%)

BioVaxys Technology Corp. (BIOV)

*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.

Citation

Quantité demandé
30,000 
Cours acheteur
0.04 
Cours vendeur
0.045 
Quantité offerte
315,000 
Volume
723,971 
Dernier prix
0.04 
Écart minimum
Up 
variation nette
0.005 
Clôture précédente
0.035 
Ouverture
0.04 
Day High
0.04 
Day Low
0.04 
Haut 52 semaines
0.085 
Bas 52 semaines
0.035 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Quantité demandé
60,000 
Cours acheteur
0.035 
Cours vendeur
0.00 
Quantité offerte
Volume
Dernier prix
0.04 
Écart minimum
Up 
variation nette
 
Clôture précédente
0.04 
Ouverture
0.00 
Day High
0.00 
Day Low
0.00 
Haut 52 semaines
 
Bas 52 semaines
 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Citation

Quantité demandé
30,000 
Cours acheteur
0.04 
Cours vendeur
0.045 
Quantité offerte
315,000 
Volume
723,971 
Dernier prix
0.04 
Écart minimum
Up 
variation nette
0.005 
Clôture précédente
0.035 
Ouverture
0.04 
Day High
0.04 
Day Low
0.04 
Haut 52 semaines
0.085 
Bas 52 semaines
0.035 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Quantité demandé
60,000 
Cours acheteur
0.035 
Cours vendeur
0.00 
Quantité offerte
Volume
Dernier prix
0.04 
Écart minimum
Up 
variation nette
 
Clôture précédente
0.04 
Ouverture
0.00 
Day High
0.00 
Day Low
0.00 
Haut 52 semaines
 
Bas 52 semaines
 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Profondeur de marche par ordre

  • BIOV / Dernière mise à jour: 15:59:51 ET
  • Refresh
  • Info
Courtier Bid Quantité demandé Cours acheteur Cours vendeur Quantité offerte Demandez Broker
RBC Capital Markets 3,000 0.04 0.045 100,000 CIBC World Markets Inc.
TD Securities Inc. 1,000 0.04 0.045 1,000 National Bank Financial Inc.
TD Securities Inc. 1,000 0.04 0.045 1,000 National Bank Financial Inc.
TD Securities Inc. 7,000 0.04 0.045 20,000 Scotia Capital Inc.
RBC Capital Markets 18,000 0.04 0.045 40,000 TD Securities Inc.
Desjardins Securities Inc. 180,000 0.035 0.045 40,000 TD Securities Inc.
CIBC World Markets Inc. 50,000 0.035 0.045 51,000 CIBC World Markets Inc.
TD Securities Inc. 1,000 0.035 0.045 20,000 Questrade Inc.
W.D. Latimer Co. Limited 25,000 0.035 0.045 1,000 National Bank Financial Inc.
TD Securities Inc. 15,000 0.035 0.045 1,000 National Bank Financial Inc.
Courtier Bid Quantité demandé Cours acheteur Cours vendeur Quantité offerte Demandez Broker
Anonymous 60,000 0.035 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0

Profondeur d'affichage de prix

  • BIOV / Dernière mise à jour: 15:59:51 ET
  • Refresh
  • Info
Acheteur Quantité demandé Cours acheteur Cours vendeur Quantité offerte Vendeur
5 30,000 0.04 0.045 315,000 11
21 863,000 0.035 0.05 2,527,000 14
10 152,000 0.03 0.055 225,000 7
5 181,000 0.025 0.06 46,000 6
3 85,000 0.02 0.065 81,000 14
Acheteur Quantité demandé Cours acheteur Cours vendeur Quantité offerte Vendeur
1 60,000 0.035 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0

Métiers récents

  • BIOV / Dernière mise à jour: 12:02:57 ET
  • Refresh
  • Info
Date/Heure Prix Modifier Volume Acheteur Vendeur Venue
Apr 22, 16:02 0.04 0.005 17,000 RBC Capital Markets Desjardins Securities Inc. CSE
Apr 22, 15:43 0.04 0.005 13,000 CIBC World Markets Inc. Desjardins Securities Inc. CSE
Apr 22, 15:39 0.04 0.005 25,000 TD Securities Inc. Anonymous CSE
Apr 22, 15:38 0.04 0.005 3,000 TD Securities Inc. Anonymous CSE
Apr 22, 15:34 0.04 0.005 1,000 National Bank Financial Inc. Anonymous CSE

Information d'entreprise

Addresse
146 Thirtieth Street
Suite 100
Etobicoke, ON M8W 3C4
Canada
Téléphone
646-452-7000
Courriel
jpassin@biovaxys.com
URL
https://biovaxys.com/
Date d’inscription à la cote
Mercredi, novembre 21, 2018
Agent de transfert
Odyssey Trust Company
Courriel
news@biovaxys.com
Vérificateur
Dale Matheson Carr-Hilton Labonte LLP

SEDAR Information

Type de dossier Tout News Releases Material Change Report Management's Discussion & Analysis Financial Statements
Délai @count semaine@count mois3 month6 month@count annéeTout le temps

Information d'entreprise

Addresse
146 Thirtieth Street
Suite 100
Etobicoke, ON M8W 3C4
Canada
Téléphone
646-452-7000
Courriel
jpassin@biovaxys.com
URL
https://biovaxys.com/
Date d’inscription à la cote
Mercredi, novembre 21, 2018
Agent de transfert
Odyssey Trust Company
Courriel
news@biovaxys.com
Vérificateur
Dale Matheson Carr-Hilton Labonte LLP

Capitalisation

Capitalisation: 
293425203
Réservé à l'émission: 
139701394

Company Officers

James Passin, CEO
Kenneth Kovan, COO & President
Christopher Cherry, Chief Financial Officer
James Passin, Chief Executive Officer
Christopher Cherry, Chief Financial Officer
Kenneth Kovan, Chief Operating Officer and President